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Another way to determine the impact of mental illness, based on the common 'cost of illness' methodology, 2 is to monetize the direct and indirect financial costs incurred by society due to mental disorders. In this framework, 'direct' costs are those associated with mental health treatment per se (e.g. medication, clinic visits, or hospitalization), whereas 'indirect costs' are incurred through premature mortality, reduced labor output (and public and private income support programs, which serve to replace labor income among the disabled), reduced educational attainment, increased incarceration and homelessness, and costs ensuing from the high rate of medical complications associated with serious mental illness. In terms of direct costs, spending on mental health treatment in the US was $100 billion in 2003, representing at least 6.2% of total health spending. 3 Indirect costs-which certainly exceed direct mental health treatment costs-have been more challenging to quantify comprehensively.
Indeed, the most recent published study to do so provided estimates for 1985, 4 which pre-dates the sweeping changes in mental health treatment patterns associated with, for example, managed behavioral healthcare and developments in psychopharmacology. 5 A recent study, however, earnings than workers without, and 25% to a higher rate of zero
earnings/non-employment among people with mental illness. 6 This estimate excludes losses due to mental health-related premature mortality, institutionalization and homelessness.
There is, of course, a kind of reciprocal relationship between direct and indirect costs: healthcare services are, in no small part, intended to preserve or restore functioning, including work and social functioning and the ability to live independently. In this context, it is particularly distressing to recognize that, despite substantial increases in the volume of mental health treatment for disorders such as depression in the past two decades, particularly pharmacotherapy, there is no evidence that the levels of morbidity or mortality from these disorders changed substantially over this period. There is also a critical need to improve the delivery of existing treatments; indeed, there are few other areas of medicine where delivery is so consistently poor. 15 The research evidence on opportunities to improve delivery of mental health care is perhaps more encouraging. For instance, there is now a large body of practical research establishing the effectiveness and cost-effectiveness of strategies to improve quality of care for depression. This is broadly referred to as 'collaborative care,' across a wide range of practice settings, delivery methods and patient populations. 16 This includes evidence from several trials that mental health quality improvement programs can improve labor outcomes. 17, 18 Moreover, there appears to be some movement toward the uptake of such programs by purchasers and implementation of them by health plans, although overall adoption remains low. 
